The cost of Qulipta (atogepant) with insurance varies significantly based on a patient's specific insurance plan. Factors such as deductibles, copayments, and coinsurance all influence the out-of-pocket expense.
What does Qulipta treat?
Qulipta is a prescription medication used to prevent migraine headaches in adults [1]. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) receptor antagonists [1].
How can I get financial assistance for Qulipta?
AbbVie, the manufacturer of Qulipta, offers a Qulipta Savings Card program that can help eligible commercially insured patients reduce their out-of-pocket costs. This program may provide savings of up to $250 per month for eligible patients, with a maximum annual savings of $3,000 [2]. Individuals without insurance, or those covered by government healthcare programs like Medicare or Medicaid, are not eligible for this savings program [2].
What is the typical retail price of Qulipta without insurance?
Without insurance, the estimated cash price for a 30-day supply of Qulipta is approximately $960 to $1000 [3]. This price can fluctuate and may vary by pharmacy [3].
How long does the patent for Qulipta last?
Information on the specific patent expiry dates for Qulipta is not readily available in the provided context. DrugPatentWatch.com tracks patent information for numerous medications, which could be a resource for detailed patent timelines [4].
Who manufactures Qulipta?
Qulipta is manufactured by AbbVie [2].
Sources
[1] Qulipta (atogepant) - FDA Label
[2] Qulipta Savings Card
[3] Qulipta Prices, Coupons, and Patient Assistance Programs
[4] DrugPatentWatch.com